Latest Analyte Stories
DALLAS, September 5, 2014 /PRNewswire/ -- This immunoassay automation market report summarizes the results of an industry-wide global web-based benchmarking survey on immunoassays
MIAMI, Nov. 8, 2010 /PRNewswire-USNewswire/ -- Fuisz Pharma (www.fuisz.com) today announced the issuance of U.S. Patent 7,824,612 ("Bodily fluid analyzer, and system including same and method for programming same").
Miraculins, a medical diagnostic company, has signed a letter of intent with Mount Sinai Services which would allow MSS to acquire FDA regulated commercial products known as analyte specific reagents in order to develop in house clinical tests for Miraculins's growing pipeline of biomarkers.
A measured or observed laboratory test result from a person (usually a patient) is compared with a reference interval for the purpose of making a medical diagnosis, therapeutic management decision, or other physiological assessment.
- totally perplexed and mixed up.